Investor relations
Management strategy
Total Commitment to Good Health
As a corporate group engaged in the medical, healthcare, and nursing care fields, the TOHO HOLDINGS Group predicts and captures the rapid changes and issues in the industry, and endeavors to improve efficiency of pharmaceutical distribution, achieve higher added value, and creating new value in related fields, so that we can contribute to extending healthy life expectancy, establishing and maintaining the sustainable social security system in this super-aging society.
Business strategy
Currently, we are promoting the Medium-term Management Plan 2026-2028 "Soaring into the Next Generation." We are accelerating our transformation into a "Comprehensive Healthcare Solutions Provider" through the following business strategies.
Pharmaceutical wholesaling business
Aim to increase gross profits by 5 billion yen based on four core strategies for medium- to long-term growth
Becoming the partner of choice in specialty pharmaceuticals
Further strengthening of high-quality logistics capabilities, including temperature control (such as cold chains) and vibration control compatible with various modalities
Contributing to market penetration of growth driver products and fostering growth domains
Category strategies by product and area and qualitative improvement of sales
Strengthening customer support system development capabilities through integration of system subsidiaries
- Developing new systems tailored to customer needs
- Integrating AI into existing systems (MIZAR, ENIFvoice, etc.)
Building a data-driven sales and delivery system by promoting Digital Transformation and utilizing AI
Leveraging BI tools and AI to improve productivity in sales and logistics
Dispensing pharmacy business
Establish a new pharmacy model that is chosen by patients and local residents by strengthening governance and promoting Digital Transformation to improve management efficiency, and by improving interpersonal services and utilizing data
Strengthening store operations
Strengthening store operations by promoting operational efficiency and standardization through enhanced governance
Expansion of new store formats
Strengthening online pharmacy and other services to meet diversifying patient needs
Boosting the productivity of pharmacists
Boosting the productivity of pharmacists by actively outsourcing prescription dispensing and promoting Digital Transformation to streamline their administrative tasks and set aside time for them for patient-facing work
Optimizing the CDP (Customer Data Platform)
Using data and AI to promote personalized communication with each patient
Pharmaceutical manufacturing and sales business
Expand CDMO business to accommodate new modalities, thereby expanding into high-value-added areas and improving profitability
Developing, manufacturing, and marketing new products by leveraging the regenerative medicine ecosystem
Providing one-stop essential functions from development to launch, and building a supply chain spanning clinical trial and wholesale logistics
Enhancement of CDMO functions centered on the Haneda Packaging Center
Expanding GMP-compliant, packaging, and storage capabilities in a bid to accept contracts from foreign-funded companies and bio-tech ventures
By integrating high-performance / high-quality logistics with CDMO and supply chains, and providing support from the development stage to foreign pharmaceutical manufacturers and bio-tech ventures that do not have infrastructure in Japan, we will expand profit opportunities from manufacturing to distribution
New businesses
Promote transformation into a Comprehensive Healthcare Solutions Provider by promoting diversification of business domains and medical Digital Transformation
Creating new businesses through proactive alliances and M&A
Going beyond the scope of the existing pharmaceutical wholesaling business, we will actively promote alliances and M&A with business companies and venture companies in peripheral areas such as CDMO, medical devices/materials, reagents, OTC drugs, medical IT, and logistics, aiming to create new value and build a solid profit base
Accelerating the expansion of the medical Digital Transformation business
Expanding into related areas using the pharmaceutical wholesaling business as a springboard to promptly provide added value and new services to our business partners, customers, and patients
Seeking new business alliances
Appointing external experts to conduct a comprehensive review of the potential of creating synergies through M&A and alliances with businesses in the same industry and those in other industries
In the light of the conclusion that sufficient added value cannot be created by simply continuing along the existing path, pursuing avenues that contribute to the creation of new value beyond the existing framework